Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology
Free Medical Books

  Lung Cancer

  Free Subscription


26.12.2011

3 AJR Am J Roentgenol
1 Am J Epidemiol
1 Ann Oncol
1 Br J Cancer
2 Cancer Chemother Pharmacol
1 Cancer Lett
1 Cancer Sci
2 Clin Lung Cancer
2 Int J Cancer
1 Int J Oncol
1 Int J Radiat Oncol Biol Phys
4 J Clin Oncol
1 J Natl Cancer Inst
3 J Nucl Med
2 Lancet Oncol
7 Lung Cancer
2 PLoS One
1 Proc Natl Acad Sci U S A


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. LACOUT A , Marcy PY, Thariat J
    Value of Combined PET/Contrast-Enhanced High-Resolution CT Fusion Imaging for Lung Cancer.
    AJR Am J Roentgenol. 2012;198:W99.
    PubMed     Text format     Related articles   


  2. KIM TJ , Park CM, Goo JM, Lee KW, et al
    Is There a Role for FDG PET in the Management of Lung Cancer Manifesting Predominantly as Ground-Glass Opacity?
    AJR Am J Roentgenol. 2012;198:83-8.
    PubMed     Text format     Related articles    Abstract available


  3. OHNO Y , Koyama H, Yoshikawa T, Matsumoto K, et al
    Diffusion-Weighted MRI Versus 18F-FDG PET/CT: Performance as Predictors of Tumor Treatment Response and Patient Survival in Patients With Non-Small Cell Lung Cancer Receiving Chemoradiotherapy.
    AJR Am J Roentgenol. 2012;198:75-82.
    PubMed     Text format     Related articles    Abstract available



    Am J Epidemiol

  4. VANDERWEELE TJ , Vansteelandt S
    A weighting approach to causal effects and additive interaction in case-control studies: marginal structural linear odds models.
    Am J Epidemiol. 2011;174:1197-203.
    PubMed     Text format     Related articles    Abstract available



    Ann Oncol

  5. SMIT EF , Socinski MA, Mullaney BP, Myrand SP, et al
    Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



    Br J Cancer

  6. FUKUDA H , Mochizuki S, Abe H, Okano HJ, et al
    Host-derived MMP-13 exhibits a protective role in lung metastasis of melanoma cells by local endostatin production.
    Br J Cancer. 2011 Oct 20. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available



    Cancer Chemother Pharmacol

  7. HIRAIKE M , Hiraki Y, Misumi N, Hanada K, et al
    Pharmacokinetics of carboplatin in a hemodialysis patient with small-cell lung cancer.
    Cancer Chemother Pharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available


  8. PEI KL , Yuan Y, Qin SH, Wang Y, et al
    CIP-13F, a novel aminopeptidase N (APN/CD13) inhibitor, inhibits Lewis lung carcinoma growth and metastasis in mice.
    Cancer Chemother Pharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available



    Cancer Lett

  9. SHEN J , Xu L, Owonikoko TK, Sun SY, et al
    NNK promotes migration and invasion of lung cancer cells through activation of c-Src/ PKCiota/ FAK loop.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available



    Cancer Sci

  10. GRAHAM B , Curry J, Smyth T, Fazal L, et al
    The HSP90 Inhibitor, AT13387, Displays a Long Duration of Action In vitro and In vivo in non-small cell lung cancer.
    Cancer Sci. 2011 Dec 19. doi: 10.1111/j.1349-7006.2011.02191.
    PubMed     Text format     Related articles    Abstract available



    Clin Lung Cancer

  11. PENG Z , Liu Q, Li M, Han M, et al
    Comparison of (11)C-Choline PET/CT and Enhanced CT in the Evaluation of Patients With Pulmonary Abnormalities and Locoregional Lymph Node Involvement in Lung Cancer.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available


  12. JIANG W , Pang XG, Wang Q, Shen YX, et al
    Prognostic Role of Twist, Slug, and Foxc2 Expression in Stage I Non-Small-Cell Lung Cancer After Curative Resection.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



    Int J Cancer

  13. HUANG B , Liu B, Yang L, Li Y, et al
    Functional genetic variants of c-Jun and their interaction with smoking and drinking increase the susceptibility to lung cancer in southern and eastern chinese.
    Int J Cancer. 2011 Dec 20. doi: 10.1002/ijc.27407.
    PubMed     Text format     Related articles    Abstract available


  14. XIAO J , Wang Y, Peng J, Guo L, et al
    A synthetic compound, 1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one (B63), induces apoptosis and activates endoplasmic reticulum stress in non-small cell lung cancer cells.
    Int J Cancer. 2011 Dec 20. doi: 10.1002/ijc.27406.
    PubMed     Text format     Related articles    Abstract available



    Int J Oncol

  15. SHIMOMURA M , Yaoi T, Itoh K, Kato D, et al
    Drug resistance to paclitaxel is not only associated with ABCB1 mRNA expression but also with drug accumulation in intracellular compartments in human lung cancer cell lines.
    Int J Oncol. 2011 Dec 13. doi: 10.3892/ijo.2011.1297.
    PubMed     Text format     Related articles    Abstract available



    Int J Radiat Oncol Biol Phys

  16. BONGERS EM , Dahele MR, Slotman BJ, Senan S, et al
    Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer: in regards to register et Al. Int j radiat oncol biol phys 2011;80:1015-1022.
    Int J Radiat Oncol Biol Phys. 2012;82:492.
    PubMed     Text format     Related articles   



    J Clin Oncol

  17. LEVY A , Magne N, Chargari C
    Computed tomography-based simulation for thoracic radiation therapy: technical advance or clinical evidence?
    J Clin Oncol. 2011;29:4335-6.
    PubMed     Text format     Related articles   


  18. SWERDLOW AJ , Higgins CD, Smith P, Cunningham D, et al
    Second Cancer Risk After Chemotherapy for Hodgkin's Lymphoma: A Collaborative British Cohort Study.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available


  19. CHANG PH , Hung MJ, Yeh KY, Yang SY, et al
    Oxaliplatin-induced coronary vasospasm manifesting as Kounis syndrome: a case report.
    J Clin Oncol. 2011;29:e776-8.
    PubMed     Text format     Related articles   


  20. SEOW H , King S, Green E, Pereira J, et al
    Perspectives of patients on the utility of electronic patient-reported outcomes on cancer care.
    J Clin Oncol. 2011;29:4213-4.
    PubMed     Text format     Related articles   



    J Natl Cancer Inst

  21. JENKS S
    Stereotactic radiation takes root in cancer therapy.
    J Natl Cancer Inst. 2011;103:1568-70.
    PubMed     Text format     Related articles   



    J Nucl Med

  22. MINAMIMOTO R , Toyohara J, Seike A, Ito H, et al
    4'-[Methyl-11C]-Thiothymidine PET/CT for Proliferation Imaging in Non-Small Cell Lung Cancer.
    J Nucl Med. 2011.
    PubMed     Text format     Related articles    Abstract available


  23. GOURNI E , Demmer O, Schottelius M, D'Alessandria C, et al
    PET of CXCR4 Expression by a 68Ga-Labeled Highly Specific Targeted Contrast Agent.
    J Nucl Med. 2011;52:1803-10.
    PubMed     Text format     Related articles    Abstract available


  24. BENZ MR , Herrmann K, Walter F, Garon EB, et al
    18F-FDG PET/CT for Monitoring Treatment Responses to the Epidermal Growth Factor Receptor Inhibitor Erlotinib.
    J Nucl Med. 2011;52:1684-9.
    PubMed     Text format     Related articles    Abstract available



    Lancet Oncol

  25. METZE K
    Pitfalls in the assessment of prognostic factors.
    Lancet Oncol. 2011;12:1095-6.
    PubMed     Text format     Related articles   


  26. LEVEQUE D
    Pharmacokinetics of gefitinib and erlotinib.
    Lancet Oncol. 2011;12:1093.
    PubMed     Text format     Related articles   



    Lung Cancer

  27. BAEK JH , Kim H, Ahn JJ, Jegal Y, et al
    Prospective phase II trial of a combination of gemcitabine and UFT as first-line treatment in elderly patients with advanced non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available


  28. ZHAO R , Yan Q, Lv J, Huang H, et al
    CHD5, a tumor suppressor that is epigenetically silenced in lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available


  29. PARK JH , Kim YJ, Lee JO, Lee KW, et al
    Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available


  30. BESSE B , Planchard D, Veillard AS, Taillade L, et al
    Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available


  31. TROBEC K , Knez L, Mesko Brguljan P, Cufer T, et al
    Estimation of renal function in lung cancer patients.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available


  32. STOVOLD R , Blackhall F, Meredith S, Hou J, et al
    Biomarkers for small cell lung cancer: Neuroendocrine, epithelial and circulating tumour cells.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available


  33. MARAMOTTI S , Paci M, Micciche F, Ciarrocchi A, et al
    Soluble epidermal growth factor receptor isoforms in non-small cell lung cancer tissue and in blood.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



    PLoS One

  34. WANG J , Chen J, Chen X, Wang B, et al
    Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis.
    PLoS One. 2011;6:e28844.
    PubMed     Text format     Related articles    Abstract available


  35. LI Q , Tainsky MA
    Epigenetic Silencing of IRF7 and/or IRF5 in Lung Cancer Cells Leads to Increased Sensitivity to Oncolytic Viruses.
    PLoS One. 2011;6:e28683.
    PubMed     Text format     Related articles    Abstract available



    Proc Natl Acad Sci U S A

  36. WANG NJ , Sanborn Z, Arnett KL, Bayston LJ, et al
    Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma.
    Proc Natl Acad Sci U S A. 2011;108:17761-6.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: